LMIM
ABBV icon

Lockheed Martin Investment Management’s AbbVie ABBV Stock Holding History

Lockheed Martin Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.3M Sell
41,130
-4,480
-10% -$964K 0.41% 55
2026
Q1 		$9.92M Buy
45,610
+470
+1% +$104K 0.36% 53
2025
Q4 		$10.3M Buy
45,140
+4,830
+12% +$1.1M 0.34% 49
2025
Q3 		$9.33M Sell
40,310
-30,390
-43% -$6.19M 0.34% 58
2025
Q2 		$13.1M Buy
70,700
+26,030
+58% +$4.84M 0.48% 41
2025
Q1 		$9.36M Sell
44,670
-1,650
-4% -$321K 0.38% 57
2024
Q4 		$8.23M Sell
46,320
-25,370
-35% -$4.66M 0.33% 60
2024
Q3 		$14.2M Buy
71,690
+19,570
+38% +$3.65M 0.66% 36
2024
Q2 		$8.94M Buy
52,120
+7,350
+16% +$1.22M 0.52% 45
2024
Q1 		$7.42M Sell
44,770
-20,880
-32% -$3.6M 0.54% 41
2023
Q4 		$9.87M Hold
65,650
– – 0.71% 37
2023
Q3 		$9.66M Buy
65,650
+19,240
+41% +$2.82M 0.74% 34
2023
Q2 		$6.25M Sell
46,410
-430
-0.9% -$63.1K 0.36% 52
2023
Q1 		$7.46M Sell
46,840
-8,260
-15% -$1.26M 0.42% 52
2022
Q4 		$8.9M Buy
+55,100
New +$8.45M 0.59% 47
2022
Q1 		– Sell
-81,150
Closed -$11M – 152
2021
Q4 		$11M Hold
81,150
– – 0.59% 47
2021
Q3 		$8.75M Buy
81,150
+11,920
+17% +$1.36M 0.47% 43
2021
Q2 		$7.8M Sell
69,230
-19,910
-22% -$2.24M 0.41% 59
2021
Q1 		$9.65M Sell
89,140
-6,430
-7% -$688K 0.49% 54
2020
Q4 		$10.2M Hold
95,570
– – 0.53% 48
2020
Q3 		$8.37M Sell
95,570
-830
-0.9% -$78.1K 0.52% 41
2020
Q2 		$9.46M Buy
+96,400
New +$8.49M 0.63% 35
2015
Q4 		– Sell
-19,750
Closed -$1.07M – 88
2015
Q3 		$1.07M Sell
19,750
-33,500
-63% -$2.18M 0.12% 63
2015
Q2 		$3.58M Buy
53,250
+45,500
+587% +$2.97M 0.18% 56
2015
Q1 		$454K Buy
+7,750
New +$468K 0.02% 115

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Lockheed Martin Investment Management's ABBV Position: Q2 2026 in Review

Lockheed Martin Investment Management reduced its AbbVie (ABBV) stake by 9.8% in Q2 2026, selling an estimated $964K and leaving 41,130 shares worth $10.3M. The position accounts for 0.41% of the portfolio, ranked #55.

Lockheed Martin Investment Management first reported a position in ABBV in Q1 2015 and has held it in 25 quarters since. The position peaked at $14.2M in Q3 2024. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Lockheed Martin Investment Management held 41,130 shares of AbbVie worth $10.3M as of Q2 2026.
  • Lockheed Martin Investment Management sold 4,480 AbbVie shares in Q2 2026, an estimated $964K.
  • AbbVie made up 0.41% of Lockheed Martin Investment Management's portfolio in Q2 2026, its #55 holding.
  • Lockheed Martin Investment Management first reported a position in AbbVie in Q1 2015 and has held it in 25 quarters since.
  • Lockheed Martin Investment Management's AbbVie position peaked at $14.2M in Q3 2024.
  • 4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.